Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

The Changing Face of Amyloidosis Referrals at a Tertiary Center over the Past 3 Decades

Andrew Staron, Lawreen H Connors, Frederick L Ruberg, John L. Berk, Lisa M Mendelson, Vaishali Sanchorawala, MD

Blood (2018) 132 (Supplement 1): 5536.

https://doi.org/10.1182/blood-2018-99-112193

Published: 2018

Journal Articles

Long-Term Update from the Open-Label Extension of the NEURO-TTR Study in Patients with Hereditary Transthyretin Amyloidosis

Thomas Brannagan, Annabel K. Wang, Teresa Coelho, Marcia Waddington Cruz, Michael J. Polydefkis, Peter J. Dyck, Violaine Plante-Bordeneuve, John L. Berk, Fabio Barroso, Giampaolo Merlini, Isabel Conceição, Steven G. Hughes, Jesse G. Kwoh, Shiangtung W. Jung, Spencer Guthrie, Michael Pollock, Merrill D. Benson, Morie A. Gertz, MD

Blood (2018) 132 (Supplement 1): 498.

https://doi.org/10.1182/blood-2018-99-116995

Published: 2018

Journal Articles

Symptoms of Depression and Anxiety Assessed By the SF-36 Questionnaire in Patients with AL Amyloidosis

Stephen Lo, Janet Shu, Margot Phillips, Fangui Sun, John L Berk, Vaishali Sanchorawala

Blood (2015) 126 (23): 3299.

https://doi.org/10.1182/blood.V126.23.3299.3299

Published: 2015

Journal Articles

Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem cell transplantation: 20-year experience

Vaishali Sanchorawala, Fangui Sun, Karen Quillen, J. Mark Sloan, John L. Berk, David C. Seldin

Blood (2015) 126 (20): 2345–2347.

https://doi.org/10.1182/blood-2015-08-662726

Published: 2015

Journal Articles

Clinical Presentation and Treatment Responses in IgM AL Amyloidosis, a Series of 106 Patients

John Mark Sloan, MD, Moussa Sissoko, MD, David C Seldin, MD PhD, Brian Sworder, MD, Kennneth Angelino, MD, Mike Broce, John L Berk, MD, Vaishali Sanchorawala, MD

Blood (2014) 124 (21): 4750.

https://doi.org/10.1182/blood.V124.21.4750.4750

Published: 2014

Journal Articles

Clinical Presentation and Treatment Responses In IgM-Related AL Amyloidosis

Moussa Sissoko, MD, Vaishali Sanchorawala, MD, David C Seldin, MD, PhD, Brian Sworder, MD, John L Berk, MD, John Mark Sloan, MD

Blood (2013) 122 (21): 1991.

https://doi.org/10.1182/blood.V122.21.1991.1991

Published: 2013

Journal Articles

High-dose melphalan and stem cell transplantation for patients with AL amyloidosis: trends in treatment-related mortality over the past 17 years at a single referral center

Stephanie B. Tsai, David C. Seldin, Karen Quillen, John L. Berk, Frederick L. Ruberg, Hans Meier-Ewert, J. Mark Sloan, Gheorghe Doros, Kathleen T. Finn, Martha Skinner, Vaishali Sanchorawala

Blood (2012) 120 (22): 4445–4446.

https://doi.org/10.1182/blood-2012-09-457341

Published: 2012

Journal Articles

High-Dose Melphalan and Stem Cell Transplantation for Patients with AL Amyloidosis and Cardiac Involvement

Saulius Girnius, M.D., David C Seldin, MD, PhD, Karen Quillen, MD, MPH, Nancy T Andrea, MD, John Mark Sloan, MD, John L Berk, MD, Frederick L Ruberg, MD, Hans Meier-Ewert, MD, Vaishali Sanchorawala, MD

Blood (2011) 118 (21): 2043.

https://doi.org/10.1182/blood.V118.21.2043.2043

Published: 2011

Journal Articles

Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients

Maria Teresa Cibeira, Vaishali Sanchorawala, David C. Seldin, Karen Quillen, John L. Berk, Laura M. Dember, Adam Segal, Frederick Ruberg, Hans Meier-Ewert, Nancy T. Andrea, J. Mark Sloan, Kathleen T. Finn, Gheorghe Doros, Joan Blade, Martha Skinner

Blood (2011) 118 (16): 4346–4352.

https://doi.org/10.1182/blood-2011-01-330738

Published: 2011

Journal Articles

Macroglossia – Not Always AL Amyloidosis

Andrew J Cowan, MD, Martha Skinner, MD, J. Mark Sloan, MD, John L Berk, MD, Carl J O'Hara, MD, David C Seldin, MD, PhD, Vaishali Sanchorawala, MD

Blood (2010) 116 (21): 5007.

https://doi.org/10.1182/blood.V116.21.5007.5007

Published: 2010

Journal Articles

Outcome of Patients with AL Amyloidosis Who Do Not Achieve Hematologic Complete Response After Treatment with High Dose Melphalan and Autologous Transplantation: Results In a Series of 421 Patients

M. Teresa Cibeira, MD, PhD, Vaishali Sanchorawala, MD, David C Seldin, MD, PhD, Karen Quillen, MD, MPH, Nancy Andrea, MD, J. Mark Sloan, MD, Kathleen T Finn, ANP, John L Berk, MD, Gheorghe Doros, PhD, Joan Blade, Martha Skinner, MD

Blood (2010) 116 (21): 2394.

https://doi.org/10.1182/blood.V116.21.2394.2394

Published: 2010

Journal Articles

Oral Cyclic Melphalan and Dexamethasone in the Treatment of Patients with AL Amyloidosis; Ineligible for High-Dose Melphalan and Stem Cell Transplantation.

Vaishali Sanchorawala, MD, David C. Seldin, MD, PhD, John Mark Sloan, MD, John L. Berk, MD, Martha Skinner

Blood (2009) 114 (22): 1883.

https://doi.org/10.1182/blood.V114.22.1883.1883

Published: 2009

Journal Articles

Treatment of AL Amyloidosis with Tandem Cycles of High Dose Melphalan and Autologous Stem Cell Transplantation: Final Analysis of a Prospective Trial.

Vaishali Sanchorawala, MD, Daniel G. Wright, MD, Karen Quillen, MD, Laura M. Dember, MD, John L. Berk, MD, Kathleen T. Finn, RN, Martha Skinner, MD, David C. Seldin, MD, PhD

Blood (2006) 108 (11): 612.

https://doi.org/10.1182/blood.V108.11.612.612

Published: 2006

Journal Articles

Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantation

David C. Seldin, Jennifer J. Anderson, Vaishali Sanchorawala, Karim Malek, Daniel G. Wright, Karen Quillen, Kathleen T. Finn, John L. Berk, Laura M. Dember, Rodney H. Falk, Martha Skinner

Blood (2004) 104 (6): 1888–1893.

https://doi.org/10.1182/blood-2004-01-0089

Published: 2004

Includes: Supplemental data

Journal Articles

Dose-Intensive Melphalan With Blood Stem-Cell Support for the Treatment of AL (Amyloid Light-Chain) Amyloidosis: Survival and Responses in 25 Patients

Raymond L. Comenzo, Evan Vosburgh, Rodney H. Falk, Vaishali Sanchorawala, Johann Reisinger, Simon Dubrey, Laura M. Dember, John L. Berk, Gorgun Akpek, Michael LaValley, Carl O'Hara, Charles F. Arkin, Daniel G. Wright, Martha Skinner

Blood (1998) 91 (10): 3662–3670.

https://doi.org/10.1182/blood.V91.10.3662

Published: 1998

NARROW

The Changing Face of Amyloidosis Referrals at a Tertiary Center over the Past 3 Decades

Long-Term Update from the Open-Label Extension of the NEURO-TTR Study in Patients with Hereditary Transthyretin Amyloidosis

Symptoms of Depression and Anxiety Assessed By the SF-36 Questionnaire in Patients with AL Amyloidosis

Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem cell transplantation: 20-year experience

Clinical Presentation and Treatment Responses in IgM AL Amyloidosis, a Series of 106 Patients

Clinical Presentation and Treatment Responses In IgM-Related AL Amyloidosis

High-dose melphalan and stem cell transplantation for patients with AL amyloidosis: trends in treatment-related mortality over the past 17 years at a single referral center

High-Dose Melphalan and Stem Cell Transplantation for Patients with AL Amyloidosis and Cardiac Involvement

Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients

Macroglossia – Not Always AL Amyloidosis

Outcome of Patients with AL Amyloidosis Who Do Not Achieve Hematologic Complete Response After Treatment with High Dose Melphalan and Autologous Transplantation: Results In a Series of 421 Patients

Oral Cyclic Melphalan and Dexamethasone in the Treatment of Patients with AL Amyloidosis; Ineligible for High-Dose Melphalan and Stem Cell Transplantation.

Treatment of AL Amyloidosis with Tandem Cycles of High Dose Melphalan and Autologous Stem Cell Transplantation: Final Analysis of a Prospective Trial.

Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantation

Dose-Intensive Melphalan With Blood Stem-Cell Support for the Treatment of AL (Amyloid Light-Chain) Amyloidosis: Survival and Responses in 25 Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only